Ventas, Inc. (NYSE:VTR) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Ventas, Inc. (NYSE:VTR) have been assigned an average recommendation of “Moderate Buy” from the seventeen analysts that are covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $95.1875.

Several research analysts have recently commented on VTR shares. Wells Fargo & Company boosted their price objective on Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Citigroup boosted their price objective on Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, May 1st. The Goldman Sachs Group reissued a “buy” rating and set a $110.00 price objective on shares of Ventas in a report on Tuesday, May 19th. KeyCorp boosted their target price on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Finally, Mizuho set a $98.00 target price on Ventas in a research report on Friday, May 22nd.

Ventas Stock Down 1.4%

Shares of NYSE VTR opened at $83.42 on Thursday. Ventas has a 12 month low of $61.76 and a 12 month high of $91.06. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $40.56 billion, a price-to-earnings ratio of 151.67, a PEG ratio of 1.82 and a beta of 0.71. The business has a 50-day moving average of $85.15 and a 200-day moving average of $82.54.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the previous year, the firm posted $0.84 EPS. The firm’s revenue for the quarter was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Sell-side analysts expect that Ventas will post 3.88 earnings per share for the current fiscal year.

Ventas Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be given a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Ventas’s payout ratio is presently 378.18%.

Insider Activity at Ventas

In related news, Director Michael J. Embler acquired 2,500 shares of the stock in a transaction on Wednesday, June 3rd. The stock was purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the transaction, the director owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the sale, the director owned 28,349 shares of the company’s stock, valued at $2,557,079.80. The trade was a 3.90% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.53% of the company’s stock.

Hedge Funds Weigh In On Ventas

A number of hedge funds and other institutional investors have recently made changes to their positions in VTR. Dynamic Wealth Strategies LLC bought a new position in shares of Ventas during the first quarter valued at approximately $25,000. GoalVest Advisory LLC bought a new position in shares of Ventas during the fourth quarter valued at approximately $26,000. Wiser Advisor Group LLC bought a new position in shares of Ventas during the third quarter valued at approximately $27,000. IFC & Insurance Marketing Inc. bought a new position in shares of Ventas during the fourth quarter valued at approximately $30,000. Finally, Elyxium Wealth LLC bought a new position in shares of Ventas during the fourth quarter valued at approximately $33,000. Institutional investors own 94.18% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.